研究と業績　2016年

研究と業績　2016年

英文

川口 知哉

  1. Kawaguchi T, Koh Y, Ando M, Ito N, Takeo S, Adachi H, Tagawa T, Kakegawa S, Yamashita M, Kataoka K, Ichinose Y, Takeuchi Y, Serizawa M, Tamiya A, Shimizu S, Yoshimoto N, Kubo A, Isa S, Saka H, Matsumura A. Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors : Japan Molecular Epidemiology for Lung Cancer Study. J Clin Oncol 2016;34:2247-2257.
  2. Mitsuoka S, Kawaguchi T, Kubo A, Isa S, Asai K, Uji M, Watanabe T, Sawa K, Yoshimoto N, Oka T, Nakai T, Suzumura T, Tanaka H, Matsuura K, Kimura T, Yoshimura N, Kudoh S, Hirata K. Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lun cancer with wild-type EGFR. Expert Opin Pharmacother 2016;17:193-203.
  3. Sawa K, Kawaguchi T, Mitsuoka S, Kusutani N, Hirata K. Pneumonitis with nonspecific interstitial pneumonia pattern caused by nivolumab in a patient with metastatic melanoma. Internal Medicine Open access 2016.

鈴村 倫弘

  1. Ota T, Suzumura T, Sugiura T, Hasegawa Y, Yonesaka K, Makihara M, Tsukuda H, Tada T, Fukuoka M. Spontaneous pneumothorax due to bronchopleural fistula following reirradiation for locoregionally recurrent squamous cell lung cancer. Clin Case Rep 2016;4:481-485.
  2. Hasegawa Y, Ota T, Tsukuda H, Suzumura T, Fukuoka M. Drug-induced Pneumonitis Following the Administration of TAS-102. Intern Med. 2016;55:2855-2859.
  3. Ota T, Nakano M, Tanaka N, Suzumura T, Miyatake N, Hasegawa Y, Ozaki T, Tsukuda H, Fukuoka M. Abdominal pain under immunosuppressive conditions. Clev Clin J Med. 2016;83:874-875.

吉本 直樹

  1. Goto K, Ohe Y, Shibata T, Seto T, Takahashi T, Nakagawa K, Tanaka H, Takeda K, Nishio M, Mori K, Satouchi M, Hida T, Yoshimura N, Kozuki T, Imamura F, Kiura K, Okamoto H, Sawa T, Tamura T. JCOG0605 investigators. Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605) : a multicentre, open-label, randomized phase 3 trial. Lancet Oncol. 2016;17:1147-1157.
  2. Yoshimoto N, Kawaguchi T, Isa S, Shimizu S, Tamiya A, Asai K, Kudoh S, Hirata K. Molecular Epidemiological Study on Passive Smoking and Estrogen Receptor Expression in Never-smokers with Non-small Cell Lung Cancer. Osaka City Medical Journal 2016;62:77-84.